IPP Bureau
Astec LifeSciences Q3FY22 PAT at Rs 24.74 cr.
By IPP Bureau - January 26, 2022
Astec LifeSciences has reported its financial performance for the quarter ended December 31, 2021
Philips introduces at-home, 12-lead ECG integrated solution for trials
By IPP Bureau - January 26, 2022
Philips expands remote cardiac monitoring portfolio with patch-based, clinical-grade ECG designed to improve patient recruitment, compliance and retention by reducing need for site visits during clinical trials
JBCPL to acquire brands from Sanzyme for Rs 628 cr
By IPP Bureau - January 26, 2022
Leading brands like Sporlac, Lobun, Oxalo, Pubergen, Nano-leo and Gynogen will now be part of the JBCPL franchise
JSW opens 300-bed covid centre in Karnataka
By IPP Bureau - January 25, 2022
The covid health center will be managed and administered by the district administration of Ballari
Agilent announces the Innovative Seahorse XF Pro Analyzer
By IPP Bureau - January 25, 2022
Optimized for pharma/biopharma to deliver a deeper understanding of cellular function
USFDA rejects Merck’s gefapixant; gain approval in Japan
By IPP Bureau - January 25, 2022
Merck is studying the Complete Response Letter and it is not related to the safety of gefapixant
Medtronic gets USFDA approval of spinal cord stimulation therapy
By IPP Bureau - January 25, 2022
Studies show significant reduction in pain and improved quality of life for patients treated with spinal cord stimulation compared to medication management alone
SQI Diagnostics inks pact with UK-Based Owlstone Medical
By IPP Bureau - January 25, 2022
Companies plan to commercialize breath-based detection of lung infection and transplant rejection
Merck donates 1.5 billionth tablet of praziquantel to Africa
By IPP Bureau - January 25, 2022
The tablet donations provided for the treatment of more than 600 million schoolchildren in affected countries in sub-Saharan Africa since 2007
Control Print’s 3-ply surgical masks receive USFDA 510(K) authorisation
By IPP Bureau - January 25, 2022
The company has been manufacturing masks since the Covid-19 outbreak in 2020
Sanofi signs as first partner of Protas
By IPP Bureau - January 25, 2022
The collaboration with Sanofi signifies a considerable investment in the UK’s Life Sciences sector and, along with other future strategic partners, has the potential to increase the pipeline of potential treatment options for a wide range of common and other life-threatening diseases
FDC’s chooses UFlex’ Asepto holographic packaging for Electral
By IPP Bureau - January 25, 2022
The six-layer packaging ensures that external media such as bacteria, light and air do not contaminate the liquid
Pfizer and BioNTech evaluate Omicron specific Covid-19 vaccine
By IPP Bureau - January 25, 2022
First participants enrolled in clinical trial received Omicron-based vaccine candidate as a two-dose primary series and as a booster dose
RaphaCure partners with Madhavbaug for cardiac healthcare services
By IPP Bureau - January 24, 2022
Madhavbaug has a pan-India presence with a vast network of 272 clinics and two hospitals
USFDA approves IND application for Allied’s cancer treatment
By IPP Bureau - January 24, 2022
APS03118 is a novel innovative drug developed by APS with global independent intellectual property rights for unlimited cancer types
